A New Path Forward for Infant Ventricular Arrhythmias
Treating life-threatening cardiac arrhythmias in newborns has long been limited by the lack of implantable defibrillator options small enough, and safe enough, for infants.
Cincinnati Children’s specialists successfully implanted an extravascular implantable cardioverter‑defibrillator (EV‑ICD) in a 6‑week‑old infant with idiopathic ventricular fibrillation (IVF), marking the youngest reported use of this technology. The case illustrates how advanced imaging, virtual surgical planning, and multidisciplinary expertise are expanding treatment options for infants previously only eligible for epicardial ICD implants.
Leveraging 3D Virtual Surgical Planning to Enable Infant EV‑ICD Therapy
Traditional ICD candidacy in infants has been constrained by patient size, anatomy and device design. At Cincinnati Children’s, advanced three-dimensional virtual surgical planning enabled successful EV‑ICD implantation in a 6‑week‑old infant, representing the youngest reported use of this technology for secondary prevention of life-threatening ventricular arrhythmia.
Using CT based imaging, clinicians created a patient specific three-dimensional model of the chest wall, mediastinum and cardiac anatomy within 24 hours. This model was used to evaluate whether a 9‑cm substernal defibrillator lead—typically considered unsuitable for infants—could be safely positioned. By modeling the lead in multiple planes, the team identified sufficient substernal space for implantation, overcoming the limitations of standard two-dimensional imaging.
“This procedure would not have been possible without three-dimensional modeling,” said Chad Connor, MD, pediatric electrophysiologist at Cincinnati Children’s. “Virtual planning confirmed that the lead could safely fit in the substernal space and allowed us to trial multiple positions before entering the operating room.”
This planning strategy builds on Cincinnati Children’s experience adapting adult‑scale cardiac technologies for pediatric use, including ventricular assist devices and complex implantable systems traditionally limited by age or weight thresholds.
Clinical Context: Idiopathic Ventricular Fibrillation in Early Infancy
The patient initially presented at approximately 1 month of age to Cincinnati Children’s Liberty Campus with fever related to a confirmed E. coli urinary tract infection. During hospitalization, the infant experienced sudden ventricular fibrillatory arrest and was successfully resuscitated with external defibrillation.
Following stabilization, the patient was transferred to the Burnet Campus for comprehensive evaluation. Diagnostic testing revealed no structural heart disease, inherited arrhythmia syndrome, medication reaction or infection severity sufficient to explain the event. Ongoing episodes of unprovoked, chaotic ventricular activity supported a diagnosis of idiopathic ventricular fibrillation.
Although rare, sudden cardiac arrhythmias in infancy carry high mortality risk, particularly in the first 6 months of life, when patients may lack identifiable structural or genetic risk factors.



